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The mechanism(s) underlying the development and maintenance ofT cell toler-
ance to self antigens is not clear, but is generally believed to involve either deletion,
"anergy" or suppression of self-reactive clones (1, 2) . Experimental attempts to dis-
criminate between these three possibilities have been severely limited by the neces-
sity of using complex functional assays to assess the presence (or absence) of self-
reactive clones . Whereas limiting dilution microassays present clear theoretical ad-
vantages over conventional assays, analysis of the tolerant state using this technology
has thus far led to controversial results (2) . Furthermore, limiting dilution assays
cannot distinguish between the clonal deletion and "anergy" models .
A more direct approach to assess the cellular basis of tolerance induction is sug-
gested by recent data (3, 4) indicating that T cell receptor (TCR) Vp domain usage
can in certain cases be strongly correlated with reactivity to specific antigens . By
exploiting such correlations, it has been possible to demonstrate that tolerance to
constitutively expressed antigens such as those encoded by MHC class I (5) and
Mlsa (4) genes is mediated via elimination of self-reactive clones . In the present ar-
ticle we have extended this approach to investigate the basis of experimentally in-
duced neonatal tolerance . Our data indicate that neonatally induced tolerance to
Mlsa antigens is likewise accompanied by the intrathymic elimination of Mlsa-
reactive cells, thus supporting the clonal deletion model .
Materials and Methods
Mice.
￿
C57BL/6, BALE/c, andDBA/2 mice were obtained from the animal facility of the
Swiss Institute for Experimental Cancer Research, Epalinges, Switzerland .
Cell Preparation.
￿
Lymph node (inguinal + axillary) or spleen cell suspensions were pre-
pared by homogenization in a loose-fitting tissue homogenizer . Cortisone-resistant thymo-
cytes (CRT) were obtained after two intraperitoneal injections of hydrocortisone acetate (4
mg/mouse), 24 h and 48 h before mice were killed .
Tolerance Induction.
￿
BALB/c mice were injected intraperitoneally with 10$ viable nucleated
DBA/2 (or control BALB/c) spleen cells within 24 h of birth .
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Monoclonal Antibodies.
￿
mAbs directed against Lyt-1 (53-7 .3) and Lyt-1.1 (7.20-6.3) were
provided by Drs. J. Ledbetter andJ . Klein, respectively. mAb KJ16-133 (6) reacts with mouse
TCR using products of the Vp8 gene family. mAb 44-22-1 was originally derived against
a H-21)"-specific cytolytic T cell clone (7). We have recently shown (Hengartner, H ., et al.,
manuscript in preparation) that this mAb reacts with all TCR using Vpr; .
Cell Culture.
￿
In some experiments, CRT from control or tolerant BALB/c mice (4 x 10'
in 2 ml) were cultured for 5 d with PMA (1 ng/ml), ionomycin (0.25 ug/ml), and human
rIL-2 (200 U/ml). Recovered cells were analyzed for expression of Vp,; and Vp as described
below.
Flow Microfluorometry (FMF).
￿
Lymph node cells or CRT (5 x 105 in 100 41) were stained
sequentially with mAbs (undiluted hybridoma culture supernatant) followed by fluoresceinated
goat anti-rat or goat anti-mouse Ig (Tago Inc., Burlingame, CA). Samples were passed on
a FACS II flow cytometer (B/D FACS Systems, Sunnyvale, CA) gated to exclude nonviable
cells. Fluorescence histograms (representing 104 viable cells) were accumulated on a loga-
rithmic scale. Data are presented as percent positive cells after subtraction of samples stained
with the fluorescent conjugate alone.
IL-2 Production and Assay.
￿
As described in detail elsewhere (8), lymph node cells from
control or tolerant BALB/c mice were depleted of CD8' cells by treatment with rat IgM
anti-Lyt-2 mAb 3.168.1 plus complement. Recovered cells (5 x 105) were cultured with 5
x 105 T cell-depleted BALB/c, DBA/2 or C57BL/6 spleen cells in 200 PI in flat-bottomed
microwells. After 48 h, supernatants were harvested and titrated for IL-2 activity on IL-2-
dependent CTLL cells. Data are expressed as IL-2 U/ml (1 U is equivalent to 0.3 ng human
rIL-2).
Results and Discussion
As expected from previous studies (9), lymph node cells from adult (8 wk) BALB/c
(H-2a, Mlsb) mice injected neonatally with DBA/2 (H-2d, Mls°) spleen cells were
tolerant to Mlsa antigens, as indicated by their inability to secrete IL-2 in response
to T cell-depleted DBA/2 spleen cells (Fig. 1) . This tolerance was specific, in that
the neonatally injected mice responded normally to third-party C57BL/6 (H-2',
Mlsb) spleen cells.
To investigate the cellular basis of this induced nonresponsive state, we took ad-
vantage of our recent observation (4) that T cell reactivity to MISA antigens in vitro
is strongly correlated with expression of TCR using the product of the Vp6 gene.
Such Vp6-bearing receptors can be readily quantitated by their specific reactivity
NEONATALLY TOLERANT
FIGURE 1 .
￿
Antigen-specific func-
tional tolerance in BALB/c (Mls6)
mice neonatally injected with
DBA/2 (Mls') spleen cells. CD8-
lymph node cells from individual
adult (8 wk) control or tolerant
BALB/c mice were stimulated with
T cell-depleted spleen cells from
syngeneic (BALB/c), Mls'-incom-
patible (DBA/2) or third-party allo-
geneic (C57BL/6) mice. Superna-
tants harvested after 48 h were
tested for IL-2 activity.A
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FIGURE 2 .
￿
Selective lack of Vp6
expression amongperipheral Tcells
CONTROL
￿
from Mls' tolerant BALB/c mice.
Lymph node cells from 8 wk-old
control or neonatally tolerant
BALB/c mice were stained with rat
mAbs detecting Vp6 (44-22-1) or
M1 sa -TOLERRNT
￿
Vas(KJ16) followed by fluorescein-
ated goat anti-rat Ig. Thin lines
represent staining with the fluores-
cent conjugate alone.
with mAb 44-22-1 (Hengartner, H., et al., manuscript in preparation) . As shown
in Fig. 2 and Table I, - 10% of lymph node cells in normal BALB/c mice were stained
by the V06-specific mAb 44-22-1, whereas -20% reacted with the control V08-
specific mAb KJ16-133 . In the lymph nodes of functionally tolerant mice, expres-
sion ofVp6 was dramatically reduced (0-3 .4%), whereas expression of Vp8 remained
at virtually normal levels (14-18%). This phenomenon was not restricted to mice
of the H-2`1 haplotype, since C3H/He (H-2k, Mlse) mice rendered neonatally
tolerant to AKR/J (H-2k, Mlsa) spleen cells likewise had very few Vp6+ T cells
(0.5-1 .2%) as compared with untreated controls (10-12 0 /0 Vp6+ ; see reference 4).
Taken together, these data demonstrate that TCR using Vp6 are selectively deficient
among peripheral T cells of mice rendered neonatally tolerant to Mlsa antigens.
The thymus is generally accepted to be the anatomical site of T cell tolerance
induction (1, 2). To determine whether the elimination of Vp6+ cells in tolerant mice
TABLE I
Expression of Vp8 and Vp6 in BALB/c Mice Neonatally Tolerant to Mls' Antigens
* Calculated after subtraction of background staining with fluorescent conjugate alone (compare Fig. 1) .
1 Data in parentheses obtained after 5 d in culture with PMA/lonomycin/IL-2 .
Spleen cells
injected
neonatally (Mls)
Cells -
Age
tested for tolerance
Tissue Mice KJ16 (VR8)
Positive cells*
44-22-1 (Vp6)
70
None (-) 8 wk Lymph node 2 18.6 9 .7
DBA/2 (a) 8 wk Lymph node 1 14.4 0.3
DBA/2 (a) 8 wk Lymph node 1 16.8 0 .7
DBA/2 (a) 8 wk Lymph node 1 17 .5 3 .4
None (-) 11 wk Lymph node 1 20.7 10.9
DBA/2 (a) 11 wk Lymph node 1 16.1 0.3
DBA/2 (a) 11 wk Lymph node 1 16.5 0.6
DBA/2 (a) 11 wk Lymph node 1 14.2 0.0
BALB/c (b) 15 d CRT 5 23.4 (25.7)1 14.2 (10.6)$
DBA/2 (a) 15 d CRT 6 18.1 (20.9)1 1 .5 (0,3)1
BALB/c (b) 7 d CRT 1 21 .5 12.4
DBA/2 (a) 7 d CRT 5 17.3 0.8
BALB/c (b) 15 d CRT 5 22.3 13.0
DBA/2 (a) 15 d CRT 5 17.2 0.82008
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occurred intrathymically or post-thymically, we therefore treated young (1-2 wk old)
neonatally tolerant mice with hydrocortisone and analyzed the resulting CRT for
expression of Vp6 and Vp8. The data from three such experiments involving a total
of 16 tolerant mice are summarized in Table I . It is clear that CRT from neonatally
tolerant (DBA/2-injected) BALB/c mice had drastically reduced levels of Vp6' cells
(0 .8-1.5%) as compared with controls injected with syngeneic BALB/c spleen cells
(13-14% Vp6+ ). As was the case with peripheral T cells, expression of Vp was only
marginally reduced as a result of tolerance induction (17-18% vs. 22-23 ,70 in the
control). Since CRT represent a thymic subpopulation phenotypically and functionally
equivalent to mature (CD4' or CD8') T cells (10), these data suggest that the elimi-
nation of Vp6' cells in neonatally tolerant mice occurs during the normal process
of intrathymic repertoire selection.
Several potential artifacts were excluded as an explanation for the apparent disap-
pearance of Vp6' T cells after neonatal tolerance induction . First, the unlikely pos-
sibility that TCR using Vp6 were modulated (rather than eliminated) after contact
with antigen in vivo was addressed by culturing the tolerant CRT for 5 further days
in the presence ofnonspecific stimuli. The resulting cells expressed the same 'MR
phenotype (0 .3% Vp6+ vs. 20.9% Vp8') as the starting population (Table I).
Second, the possibility that extensive chimerism resulted in a dilution of Vp6'
(BALB/c) T cells by Vp6" (DBA/2) T cells (4) was ruled out by phenotypic analysis
(Table II). Since BALB/c and DBA/2 mice differ at the Lyt-1 locus, it could be con-
cluded that CRT from neonatally tolerant BALB/c mice contained <1% donor-
derived DBA/2 T cells.
The clear-cut evidence presented here for a clonal deletion mechanism of neo-
natal tolerance to Mlsa antigens confirms and extends earlier limiting dilution data
indicating a dramatic reduction in functional Mlsa-specific T cell precursors in
tolerant mice (9). However the mechanism(s) responsible for elimination of self-reactive
clones remains obscure. In this regard, significant chimerism of bone marrow-de-
rived nonlymphoid cells has been detected in the thymus ofneonatally tolerant mice
(11). Such chimerism may be important in the development and/or maintenance of
the tolerant state. Alternatively, it is possible that some processed product of the
Mlsa gene may recirculate to the neonatal thymus (12) and participate in the in-
TABLE II
Lack of Detectable T Cell Chimerism in Neonatally Tolerant BALB/c Thymus
" After subtraction of background staining with fluorescent anti-rat Ig (Lyt-1) or anti-mouse
Ig (Lyt-1 .1) conjugate.
Strain
(Lyt phenotype)
Spleen cells
injected neonatally
(Mls)
Exp.
Lyt-1
Positive
1
Lyt-1 .1
CRT`
Lyt-1
Exp. 2
Lyt-1 .1
° Jc
DBA/2 None (-) 97.2 94.5 ND 93 .5
(Lyt-1 .1)
BALB/c BALB/c (b) 97 .0 0 .6 ND 0 .1
(Lyt-1 .2)
BALB/c DBA/2 (a) 96 .9 0 .5 ND 0.4MAcDONALD ET AL . BRIEF DEFINITIVE REPORT
duction of tolerance by associating with appropriate host components, in analogy
with models of presentation of immunogenic peptides by MHC class II molecules
(13) . Whatever the explanation, the model system described here should facilitate
analysis of the cellular and molecular events associated with the establishment of
immunological tolerance.
Summary
The cellular basis of neonatally induced T cell tolerance has been investigated
in a model system in which usage of a particular TCR Vp segment (VP6) is strongly
correlated with reactivity to antigens encoded by the Mls" genetic locus . Expres-
sion of V06 by peripheral T cells was virtually abolished in BALB/c (H-2", Mls")
mice rendered neonatally tolerant to DBA/2 (H-2", Mls'') lymphoid cells, whereas
control V08-bearing T cells remained at near normal levels . Further analysis re-
vealed that elimination ofVph + T cells occurred in the thymus of neonatally tolerant
miceand could not be explained by receptor modulation orT cell chimerism . These
data thus support the clonal deletion model of tolerance induction .
We thank A . Porret and N . Jeanguenat for expert technical assistance, E . Santoli for FACS
analysis, and P . Brunet for preparation of the manuscript .
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